Exact Mass: 494.3362556

Exact Mass Matches: 494.3362556

Found 82 metabolites which its exact mass value is equals to given mass value 494.3362556, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

1-docosanoyl-glycero-3-phosphate

[(2R)-3-(docosanoyloxy)-2-hydroxypropoxy]phosphonic acid

C25H51O7P (494.3372226)


1-docosanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-docosanoyl-glycero-3-phosphate is considered to be practically insoluble (in water) and acidic. 1-docosanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

   

LysoPA(22:0/0:0)

[3-(docosanoyloxy)-2-hydroxypropoxy]phosphonic acid

C25H51O7P (494.3372226)


LysoPA(22:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(22:0/0:0), in particular, consists of one chain of behenic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

   

LysoPA(i-22:0/0:0)

{2-hydroxy-3-[(20-methylhenicosanoyl)oxy]propoxy}phosphonic acid

C25H51O7P (494.3372226)


LysoPA(i-22:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-22:0/0:0), in particular, consists of one chain of isodocosanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

   
   

beta-fenchyl Delta9-tetrahydrocannabinolate

beta-fenchyl Delta9-tetrahydrocannabinolate

C32H46O4 (494.3395916)


   

bornyl Delta9-tetrahydrocannabinolate

bornyl Delta9-tetrahydrocannabinolate

C32H46O4 (494.3395916)


   

deoxyfurohyperforin A

deoxyfurohyperforin A

C32H46O4 (494.3395916)


   

3beta-acetoxyglutina-5(10),6-dien-27,8alpha-olide|phyllenolide A

3beta-acetoxyglutina-5(10),6-dien-27,8alpha-olide|phyllenolide A

C32H46O4 (494.3395916)


   

4-terpenyl Delta9-tetrahydrocannabinolate

4-terpenyl Delta9-tetrahydrocannabinolate

C32H46O4 (494.3395916)


   

alpha-terpenyl Delta9-tetrahydrocannabinolate

alpha-terpenyl Delta9-tetrahydrocannabinolate

C32H46O4 (494.3395916)


   

Ganodermic acid TQ

Ganodermic acid TQ

C32H46O4 (494.3395916)


   
   
   

1-(3,7-dimethylocta-2,6-dienyl)-6,6,10,10-tetramethyl-11-(2-methylpropanoyl)tetracyclo[7.3.1.13,11.03,7]tetradecane-2,12,14-trione|hypersampsone C

1-(3,7-dimethylocta-2,6-dienyl)-6,6,10,10-tetramethyl-11-(2-methylpropanoyl)tetracyclo[7.3.1.13,11.03,7]tetradecane-2,12,14-trione|hypersampsone C

C32H46O4 (494.3395916)


   

(2-{6-[3-(2-dimethylamino-ethyl)-indol-2-yl]-7,7,9-trimethyl-6a,7,8,10a-tetrahydro-6H-isoindolo[2,1-a]indol-11-yl}-ethyl)-methyl-amine|4-Methyl-isoborreverin|Methyl-4-Isoborreverin

(2-{6-[3-(2-dimethylamino-ethyl)-indol-2-yl]-7,7,9-trimethyl-6a,7,8,10a-tetrahydro-6H-isoindolo[2,1-a]indol-11-yl}-ethyl)-methyl-amine|4-Methyl-isoborreverin|Methyl-4-Isoborreverin

C33H42N4 (494.3409292)


   

(8R,9S,22R)-3-ethoxy-3-oxo-9,19-cyclo-3,4-secolanosta-4(28),6,24-trien-26-oic acid 22,26-lactone

(8R,9S,22R)-3-ethoxy-3-oxo-9,19-cyclo-3,4-secolanosta-4(28),6,24-trien-26-oic acid 22,26-lactone

C32H46O4 (494.3395916)


   

(5Z,7E)-(1S,3R)-18-[m-(1-hydroxy-1-methylethyl)-benzyloxy]-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

1α-hydroxy-18-[m-(1-hydroxy-1-methylethyl)-benzyloxy]-23,24,25,26,27-pentanorvitamin D3 / 1α-hydroxy-18-[m-(1-hydroxy-1-methylethyl)-benzyloxy]-23,24,25,26,27-pentanorcholecalciferol

C32H46O4 (494.3395916)


   

Atocalcitol

(5Z,7E)-(1S,3R)-23-oxa-24-[3-(1-hydroxy-1-methylethyl)phenyl]-25,26,27-trinor-9,10-seco-5,7,10(19)-cholestatriene-1,3-diol

C32H46O4 (494.3395916)


   

PA(22:0/0:0)

1-docosanoyl-glycero-3-phosphate

C25H51O7P (494.3372226)


   

LPA 22:0

1-docosanoyl-glycero-3-phosphate

C25H51O7P (494.3372226)


   

Guanethidine sulfate

Guanethidine sulfate

C20H46N8O4S (494.3362556)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents

   

[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl] docosanoate

[(2R)-1-hydroxy-3-phosphonooxypropan-2-yl] docosanoate

C25H51O7P (494.3372226)


   

Guanethidine bisulfate

Guanethidine bisulfate

C20H46N8O4S (494.3362556)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents

   

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

C29H50O4S (494.34296200000006)


   

1-docosanoyl-glycero-3-phosphate

1-docosanoyl-glycero-3-phosphate

C25H51O7P (494.3372226)


   

FAHFA 10:1/O-22:7

FAHFA 10:1/O-22:7

C32H46O4 (494.3395916)


   

FAHFA 10:2/O-22:6

FAHFA 10:2/O-22:6

C32H46O4 (494.3395916)


   

FAHFA 10:3/O-22:5

FAHFA 10:3/O-22:5

C32H46O4 (494.3395916)


   

FAHFA 11:1/O-21:7

FAHFA 11:1/O-21:7

C32H46O4 (494.3395916)


   

FAHFA 11:2/O-21:6

FAHFA 11:2/O-21:6

C32H46O4 (494.3395916)


   

FAHFA 11:3/O-21:5

FAHFA 11:3/O-21:5

C32H46O4 (494.3395916)


   

FAHFA 12:2/O-20:6

FAHFA 12:2/O-20:6

C32H46O4 (494.3395916)


   

FAHFA 12:3/O-20:5

FAHFA 12:3/O-20:5

C32H46O4 (494.3395916)


   

FAHFA 12:4/O-20:4

FAHFA 12:4/O-20:4

C32H46O4 (494.3395916)


   

FAHFA 13:2/O-19:6

FAHFA 13:2/O-19:6

C32H46O4 (494.3395916)


   

FAHFA 13:3/O-19:5

FAHFA 13:3/O-19:5

C32H46O4 (494.3395916)


   

FAHFA 13:4/O-19:4

FAHFA 13:4/O-19:4

C32H46O4 (494.3395916)


   

FAHFA 14:2/O-18:6

FAHFA 14:2/O-18:6

C32H46O4 (494.3395916)


   

FAHFA 14:3/O-18:5

FAHFA 14:3/O-18:5

C32H46O4 (494.3395916)


   

FAHFA 14:4/O-18:4

FAHFA 14:4/O-18:4

C32H46O4 (494.3395916)


   

FAHFA 15:3/O-17:5

FAHFA 15:3/O-17:5

C32H46O4 (494.3395916)


   

FAHFA 15:4/O-17:4

FAHFA 15:4/O-17:4

C32H46O4 (494.3395916)


   

FAHFA 15:5/O-17:3

FAHFA 15:5/O-17:3

C32H46O4 (494.3395916)


   

FAHFA 16:3/O-16:5

FAHFA 16:3/O-16:5

C32H46O4 (494.3395916)


   

FAHFA 16:4/O-16:4

FAHFA 16:4/O-16:4

C32H46O4 (494.3395916)


   

FAHFA 16:5/O-16:3

FAHFA 16:5/O-16:3

C32H46O4 (494.3395916)


   

FAHFA 17:3/O-15:5

FAHFA 17:3/O-15:5

C32H46O4 (494.3395916)


   

FAHFA 17:4/O-15:4

FAHFA 17:4/O-15:4

C32H46O4 (494.3395916)


   

FAHFA 17:5/O-15:3

FAHFA 17:5/O-15:3

C32H46O4 (494.3395916)


   

FAHFA 18:4/O-14:4

FAHFA 18:4/O-14:4

C32H46O4 (494.3395916)


   

FAHFA 18:5/O-14:3

FAHFA 18:5/O-14:3

C32H46O4 (494.3395916)


   

FAHFA 18:6/O-14:2

FAHFA 18:6/O-14:2

C32H46O4 (494.3395916)


   

FAHFA 19:4/O-13:4

FAHFA 19:4/O-13:4

C32H46O4 (494.3395916)


   

FAHFA 19:5/O-13:3

FAHFA 19:5/O-13:3

C32H46O4 (494.3395916)


   

FAHFA 19:6/O-13:2

FAHFA 19:6/O-13:2

C32H46O4 (494.3395916)


   

FAHFA 20:4/O-12:4

FAHFA 20:4/O-12:4

C32H46O4 (494.3395916)


   

FAHFA 20:5/O-12:3

FAHFA 20:5/O-12:3

C32H46O4 (494.3395916)


   

FAHFA 20:6/O-12:2

FAHFA 20:6/O-12:2

C32H46O4 (494.3395916)


   

FAHFA 21:5/O-11:3

FAHFA 21:5/O-11:3

C32H46O4 (494.3395916)


   

FAHFA 21:6/O-11:2

FAHFA 21:6/O-11:2

C32H46O4 (494.3395916)


   

FAHFA 21:7/O-11:1

FAHFA 21:7/O-11:1

C32H46O4 (494.3395916)


   

FAHFA 22:5/O-10:3

FAHFA 22:5/O-10:3

C32H46O4 (494.3395916)


   

FAHFA 22:6/O-10:2

FAHFA 22:6/O-10:2

C32H46O4 (494.3395916)


   

FAHFA 22:7/O-10:1

FAHFA 22:7/O-10:1

C32H46O4 (494.3395916)